New animal models for autoimmune hepatitis

Seminars in Liver Disease

Volumn 29, Issue 3, 2009, Pages 262-272

  Christen, Urs ^a   Hintermann, Edith ^a   Jaeckel, Elmar ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CYP2D6; Fibrosis; FTCD; Mimicry; Virus infection

Indexed keywords

CYTOCHROME P450 2D6; CYTOKINE;

AUTOIMMUNE HEPATITIS; DISEASE MODEL; HUMAN; IMMUNOPATHOGENESIS; LIVER CELL; LIVER INJURY; LIVER PARENCHYMA; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TRANSGENIC MOUSE;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; CYTOCHROME P-450 CYP2D6; CYTOKINES; DISEASE MODELS, ANIMAL; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; LIVER; MICE; MICE, TRANSGENIC; SPECIES SPECIFICITY;

EID: 68849095162     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0029-1233536     Document Type: Review

References (78)

1. Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31(5): 929-938
2. Ichiki Y, Shimoda S, Ishibashi H, Gershwin ME. Is primary biliary cirrhosis a model autoimmune disease? Autoimmun Rev 2004;3(4):331-336
3. Calne RY, Sells RA, Pena JR, et al. Induction of immunological tolerance by porcine liver allografts. Nature 1969;223(5205):472-476
4. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994;19(4):916-924
5. Kamada N. The immunology of experimental liver transplantation in the rat. Immunology 1985;55(3):369-389
6. Bumgardner GL, Li J, Heininger M, Ferguson RM, Orosz CG. In vivo immunogenicity of purified allogeneic hepatocytes in a murine hepatocyte transplant model. Transplantation 1998;65(1):47-52
7. Nelson SD, Pearson PG. Covalent and noncovalent interactions in acute lethal cell injury caused by chemicals. Annu Rev Pharmacol Toxicol 1990;30:169-195
8. Park BK, Kitteringham NR. Drug-protein conjugation and its immunological consequences. Drug Metab Rev 1990;22(1): 87-144
9. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004;114(5):701-712
10. Limmer A, Ohl J, Kurts C, et al. Efficient presentation of exogenous antigen by liver endothelial cells to CD8+T cells results in antigen-specific T-cell tolerance. Nat Med 2000; 6(12):1348-1354
11. Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003;3(1):51-62
12. Chen CH, Kuo LM, Chang Y, et al. In vivo immune modulatory activity of hepatic stellate cells in mice. Hepatology 2006;44(5):1171-1181
13. Lüth S, Huber S, Schramm C, et al. Ectopic expression of neural autoantigen in mouse liver suppresses experimental autoimmune neuroinflammation by inducing antigen-specific Tregs. J Clin Invest 2008;118(10):3403-3410
14. Büschenfelde KH, Kössling FK, Miescher PA. Experimental chronic active hepatitis in rabbits following immunization with human liver proteins. Clin Exp Immunol 1972;11(1):99-108
15. Kuriki J, Murakami H, Kakumu S, et al. Experimental autoimmune hepatitis in mice after immunization with syngeneic liver proteins together with the polysaccharide of Klebsiella pneumoniae. Gastroenterology 1983;84(3):596-603
16. Baxter AG. The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 2007; 7(11):904-912
17. Lohse AW, Manns M, Dienes HP, Meyer zum Büschenfelde KH, Cohen IR. Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity. Hepatology 1990;11(1):24-30
18. Watanabe Y, Kawakami H, Kawamoto H, et al. Effect of neonatal thymectomy on experimental autoimmune hepatitis in mice. Clin Exp Immunol 1987;67(1):105-113
19. Asano M, Toda M, Sakaguchi N, Sakaguchi S. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med 1996;184(2):387-396
20. Shevach EM. CD4+CD25+suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2(6):389-400
21. Lohse AW, Dienes HP, Meyer zum Büschenfelde KH. Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression. Hepatology 1998; 27(6):1536-1543
22. Panoutsakopoulou V, Huster KM, McCarty N, et al. Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J Clin Invest 2004;113(8):1218-1224
23. Jaeckel E. Animal models of autoimmune hepatitis. Semin Liver Dis 2002;22(4):325-338
24. Tiegs G. Experimental hepatitis and role of cytokines. Acta Gastroenterol Belg 1997;60(2):176-179
25. Toyonaga T, Hino O, Sugai S, et al. Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver. Proc Natl Acad Sci U S A 1994;91(2):614-618
26. Hussain MJ, Mustafa A, Gallati H, Mowat AP, Mieli-Vergani G, Vergani D. Cellular expression of tumour necrosis factor-alpha and interferon-gamma in the liver biopsies of children with chronic liver disease. J Hepatol 1994;21(5):816-821
27. Tiegs G, Hentschel J, Wendel AA. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992;90(1):196-203
28. Küsters S, Gantner F, Künstle G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996; 111(2):462-471
29. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995; 21(1):190-198
30. Gantner F, Leist M, Küsters S, Vogt K, Volk HD, Tiegs G. T cell stimulus-induced crosstalk between lymphocytes and liver macrophages results in augmented cytokine release. Exp Cell Res 1996;229(1):137-146
31. Knolle PA, Gerken G, Loser E, et al. Role of sinusoidal endothelial cells of the liver in concanavalin A-induced hepatic injury in mice. Hepatology 1996;24(4):824-829
32. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci U S A 2000;97(10):5498-5503
33. Gantner F, Leist M, Jilg S, Germann PG, Freudenberg MA, Tiegs G. Tumor necrosis factor-induced hepatic DNA fragmentation as an early marker of T cell-dependent liver injury in mice. Gastroenterology 1995;109(1):166-176
34. Leist M, Gantner F, Bohlinger I, Germann PG, Tiegs G, Wendel A. Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-alpha requires transcriptional arrest. J Immunol 1994;153(4):1778-1788
35. Manns MP, Johnson EF, Griffin KJ, Tan EM, Sullivan KF. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. J Clin Invest 1989;83(3):1066-1072
36. Zanger UM, Hauri HP, Loeper J, Homberg JC, Meyer UA. Antibodies against human cytochrome P-450db1 in autoimmune hepatitis type II. Proc Natl Acad Sci U S A 1988; 85(21):8256-8260
37. Derbinski J, Schulte A, Kyewski B, Klein L. Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self. Nat Immunol 2001;2(11):1032-1039
38. Klein L, Klein T, Rüther U, Kyewski B. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med 1998;188(1):5-16
39. Klein L, Kyewski B. "Promiscuous" expression of tissue antigens in the thymus: a key to T-cell tolerance and autoimmunity? J Mol Med 2000;78(9):483-494
40. Ando K, Guidotti LG, Wirth S, et al. Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J Immunol 1994;152(7):3245-3253
41. Moriyama T, Guilhot S, Klopchin K, et al. Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice. Science 1990;248(4953):361-364
42. Ferber I, Schönrich G, Schenkel J, Mellor AL, Hämmerling GJ, Arnold B. Levels of peripheral T cell tolerance induced by different doses of tolerogen. Science 1994;263(5147):674-676
43. Schönrich G, Kalinke U, Momburg F, et al. Downregulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 1991;65(2):293-304
44. Schönrich G, Alferink J, Klevenz A, et al. Tolerance induction as a multi-step process. Eur J Immunol 1994;24(2):285-293
45. Alferink J, Schittek B, Schönrich G, Hämmerling GJ, Arnold B. Long life span of tolerant T cells and the role of antigen in maintenance of peripheral tolerance. Int Immunol 1995;7(2):331-336
46. Schönrich G, Momburg F, Malissen M, et al. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol 1992;4(5):581-590
47. Heath WR, Allison J, Hoffmann MW, et al. Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature 1992;359(6395):547-549
48. Limmer A, Sacher T, Alferink J, et al. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur J Immunol 1998; 28(8):2395-2406
49. Sacher T, Knolle P, Nichterlein T, Arnold B, Hämmerling GJ, Limmer A. CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoaggression against hepatocytes. Eur J Immunol 2002;32(12):3628-3637
50. Bertolino P, Bowen DG, McCaughan GW, Fazekas de St Groth B. Antigen-specific primary activation of CD8+T cells within the liver. J Immunol 2001;166(9):5430-5438
51. Bertolino P, Heath WR, Hardy CL, Morahan G, Miller JF. Peripheral deletion of autoreactive CD8+T cells in transgenic mice expressing H-2Kb in the liver. Eur J Immunol 1995;25(7):1932-1942
52. Morahan G, Brennan FE, Bhathal PS, Allison J, Cox KO, Miller JF. Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc Natl Acad Sci U S A 1989;86(10):3782-3786
53. Rocha B, von Boehmer H. Peripheral selection of the T cell repertoire. Science 1991;251(4998):1225-1228
54. Bertolino P, Trescol-Biémont MC, Rabourdin-Combe C. Hepatocytes induce functional activation of naive CD8+T lymphocytes but fail to promote survival. Eur J Immunol 1998;28(1):221-236
55. Bertolino P, Trescol-Biémont MC, Thomas J, et al. Death by neglect as a deletional mechanism of peripheral tolerance. Int Immunol 1999;11(8):1225-1238
56. Derkow K, Loddenkemper C, Mintern J, et al. Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis. Hepatology 2007;46(4): 1155-1165
57. von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 2003;1(2):151-157
58. Voehringer D, Blaser C, Grawitz AB, Chisari FV, Buerki K, Pircher H. Break of T cell ignorance to a viral antigen in the liver induces hepatitis. J Immunol 2000;165(5):2415-2422
59. Oldstone MBA, Nerenberg M, Southern P, Price J, Lewicki H. Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response. Cell 1991;65(2):319-331
60. Ohashi PS, Oehen S, Buerki K, et al. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell 1991;65(2):305-317
61. Christen U, von Herrath MG. Initiation of autoimmunity. Curr Opin Immunol 2004;16(6):759-767
62. von Herrath MG, Dockter J, Oldstone MBA. How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model. Immunity 1994;1(3):231-242
63. Djilali-Saiah I, Lapierre P, Vittozi S, Alvarez F. DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis. J Immunol 2002;169(9):4889-4896
64. Lapierre P, Djilali-Saiah I, Vitozzi S, Alvarez F. A murine model of type 2 autoimmune hepatitis: xenoimmunization with human antigens. Hepatology 2004;39(4):1066-1074
65. Tamaki S, Homma S, Enomoto Y, et al. Autoimmune hepatic inflammation by vaccination of mice with dendritic cells loaded with well-differentiated hepatocellular carcinoma cells and administration of interleukin-12. Clin Immunol 2005;117(3):280-293
66. Trembleau S, Penna G, Gregori S, et al. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J Immunol 1999;163(5):2960-2968
67. Trembleau S, Penna G, Gregori S, Giarratana N, Adorini L. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma. J Immunol 2003;170(11): 5491-5501
68. Zaccone P, Hutchings P, Nicoletti F, Penna G, Adorini L, Cooke A. The involvement of IL-12 in murine experimentally induced autoimmune thyroid disease. Eur J Immunol 1999;29(6):1933-1942
69. Zierden M, Kühnen E, Odenthal M, Dienes HP. Spontaneous chronic liver inflammation in a transgenic mouse model of autoimmune hepatitis: impact and regulation of antigen-specific CD8+ T-cells. Paper presented at 2008 EASL Monothematic Conference: Immune Mediated Liver Injury; Hamburg, Germany. December 4-6
70. Oldstone MBA. Molecular mimicry and autoimmune disease. Cell 1987;50(6):819-820
71. Rose NR, Mackay IR. Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci 2000;57(4):542-551
72. Oldstone MB. Molecular mimicry and immune-mediated diseases. FASEB J 1998;12(13):1255-1265
73. Christen U, Edelmann KH, McGavern DB, et al. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J Clin Invest 2004;114(9): 1290-1298
74. Croxford JL, Anger HA, Miller SD. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry. J Immunol 2005;174(2):907-917
75. Christen U, von Herrath MG. Induction, acceleration or prevention of autoimmunity by molecular mimicry. Mol Immunol 2004;40(14-15):1113-1120
76. Holdener M, Hintermann E, Bayer M, et al. Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection. J Exp Med 2008;205(6):1409-1422
77. Corchero J, Granvil CP, Akiyama TE, et al. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse. Mol Pharmacol 2001;60(6):1260-1267
78. Fischer K, Wolenski M, Manns MP, Jaeckel E. A new animal model of chronic autoimmune hepatitis mediated by the adaptive immune system. Paper presented at: 2008 EASL Monothematic Conference: Immune Mediated Liver Injury; Hamburg, Germany; December 4-6, 2008